PO-1408 Two-fraction prostate SABR vs. two-fraction HDR brachytherapy: does dose heterogeneity matter?. (May 2022) - Correa, R.; Morton, G.; Chung, H.; Tseng, C.; Cheung, P.; Chu, W.; Liu, S.; McGuffin, M.; Shahid, A.; Davidson, M.; Ravi, A.; Helou, J.; et al.